As the country sees an exponential rise in Covid cases, with India reporting over 10,000 daily in 24 hours on Wednesday, we revisit the importance of the world's first nasal vaccine.
Bharat Biotech's iNCOVACC has received Emergency Use approval from the Drugs Controller General of India, making it the world's first intransal vaccine to be used for patients of 18 years or older.
The recovery count increased by one and reached 11,63,628, leaving the state with three active cases, he added.
These vaccines could be more effective as they'd train nose and mouth against coronavirus – the most common ways of viral entry into humans.
The nasal vaccine BBV154 received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.
